[Brokerage Focus] China Securities Co.,Ltd.: Bullish on pharmaceutical companies to stabilize domestic foundations while actively exploring overseas markets.

Gold Wujia News | China Securities Co.,Ltd. issued a Research Report indicating that under the backdrop of restructuring the Global pattern, the China Meheco Group Industry needs to "base itself internally and expand externally," promoting technological self-control, accelerating international layout, addressing tariff policies and geopolitical challenges, and seizing opportunities from the transformation of the Global Pharmaceutical Industry Chain. In this round of tariffs imposed by the USA on China, there is a phased exemption for Pharmaceuticals, and the export of Innovative Drugs mainly involves IP transfer, which has a limited impact. For the Medical Device Industry, the firm is long-term Bullish on self-control and the trend of Medical Device exports. Looking ahead to future investment opportunities in the Industry, the firm is Bullish on pharmaceutical companies stabilizing their domestic foundation, actively participating in industry consolidation, externally keeping pace and paths, and proactively exploring overseas markets.